Pharmaceuticals, Biotechnology and Life Sciences
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholdersSAN MATEO, Calif., June 18, 2025 (GLOBE…
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused…
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2…
– First use of camel hemoglobin as a universal oxygen carrier – Unique properties make it an ideal ingredient for…
– New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay,…
Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have…
Live webcast on Wednesday, June 25th at 12:00 PM ETISELIN, N.J., June 18, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc.…
Combination of World Leading Epitranscriptomics and AI-Driven Automation Aims to Accelerate Development of Cancer Therapies That Halt MetastasisMENLO PARK, Calif.…
MIDDLETON, Wis. and SARASOTA, Fla., June 18, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the…
Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of…